Cibc World Markets Corp Zentalis Pharmaceuticals, Inc. Call Options Transaction History
Cibc World Markets Corp
- $12.4 Billion
- Q1 2025
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding ZNTL
# of Institutions
139Shares Held
60.5MCall Options Held
7.9KPut Options Held
42.5K-
Matrix Capital Management Company, LP Waltham, MA14MShares$18.3 Million6.94% of portfolio
-
Black Rock Inc. New York, NY4.82MShares$6.31 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.26MShares$4.27 Million0.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny3.07MShares$4.02 Million0.0% of portfolio
-
Acadian Asset Management LLC Boston, MA2.67MShares$3.5 Million0.01% of portfolio
About Zentalis Pharmaceuticals, Inc.
- Ticker ZNTL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 56,983,600
- Market Cap $74.6M
- Description
- Zentalis Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on discovering and developing small molecule therapeutics for the treatment of various cancers. Its lead product candidate includes the ZN-c3, an inhibitor of WEE1, a protein tyrosine kinase, which is in Phase 2 clinical trial for the treatment of advanced solid ...